In a patient with indirect hyperbilirubinemia, normal transaminases, elevated alkaline phosphatase, leukocytosis, thrombocytopenia, fever, chills, acute urinary retention, and negative viral markers, what is the most likely diagnosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Thrombotic Thrombocytopenic Purpura (TTP)

Based on the clinical presentation of indirect hyperbilirubinemia (total bilirubin 8.4 with direct 1.0), thrombocytopenia (platelets 90,000), fever, chills, leukocytosis, elevated ALP, and acute urinary retention with negative viral markers, the most likely diagnosis is Thrombotic Thrombocytopenic Purpura (TTP), and this patient requires immediate hematology consultation and urgent plasma exchange therapy.

Clinical Reasoning

This patient presents with the classic pentad components of TTP, though importantly, the complete pentad is present in fewer than 5% of cases 1. The key diagnostic features here are:

Critical Diagnostic Elements

  • Microangiopathic hemolytic anemia: The marked indirect hyperbilirubinemia (7.4 mg/dL unconjugated) with normal transaminases indicates hemolysis rather than hepatocellular injury 2, 3
  • Thrombocytopenia: Platelet count of 90,000 represents significant thrombocytopenia
  • Fever and systemic symptoms: Present with chills
  • Renal involvement: Acute urinary retention suggests renal dysfunction, a common TTP manifestation
  • Normal transaminases: AST 28 and ALT 23 effectively rule out hepatocellular injury

Why This is TTP and Not Other Diagnoses

The pattern of indirect hyperbilirubinemia with normal transaminases is pathognomonic for hemolysis, not liver disease 2, 3. The elevated ALP (213) likely reflects the systemic inflammatory state rather than cholestasis, as the direct bilirubin remains low (1.0).

TTP characteristically presents with:

  • Fever and microangiopathic hemolytic anemia
  • Thrombocytopenia (often severe)
  • Renal dysfunction
  • Neurological manifestations (which can include urinary retention from autonomic involvement)
  • Fluctuating symptoms 1

The negative viral markers exclude viral hepatitis, and the clinical picture does not fit hemolytic uremic syndrome (HUS), which typically presents with bloody diarrhea 4, 5.

Immediate Management Algorithm

Step 1: Emergency Stabilization (Within Hours)

  • Immediate hematology consultation - delay in identification is associated with increased mortality 4
  • Obtain peripheral blood smear to confirm schistocytes
  • Check ADAMTS13 activity level and inhibitor titer
  • Measure LDH, haptoglobin, reticulocyte count to confirm hemolysis
  • PT, aPTT, fibrinogen to exclude DIC
  • Direct antiglobulin test (Coombs)
  • Blood type and cross-match for plasma exchange 4

Step 2: Initiate Plasma Exchange (Same Day)

For this Grade 4 presentation (life-threatening with renal failure):

  • Initiate plasma exchange (PEX) immediately according to existing guidelines 4
  • Administer methylprednisolone 1 g IV daily for 3 days, with first dose immediately after first PEX 4
  • Consider rituximab for severe cases 4

Step 3: Supportive Care

  • Manage acute urinary retention with catheterization
  • Avoid platelet transfusions unless life-threatening bleeding (can worsen thrombosis)
  • Monitor renal function closely; prepare for possible hemodialysis
  • Serial monitoring of platelet count, hemoglobin, LDH, and renal function

Critical Pitfalls to Avoid

  1. Do not delay treatment waiting for ADAMTS13 results - TTP is a clinical diagnosis and treatment must begin immediately based on clinical suspicion 1

  2. Do not misinterpret the hyperbilirubinemia as liver disease - the indirect pattern with normal transaminases confirms hemolysis, not hepatocellular injury 2, 3

  3. Do not transfuse platelets routinely - this can worsen microvascular thrombosis in TTP 4

  4. Do not attribute symptoms to sepsis alone - while the leukocytosis and fever may suggest infection, the combination with thrombocytopenia and hemolysis points to TTP. The procalcitonin of 0.03 is reassuringly low and argues against bacterial sepsis 6

Alternative Considerations (Less Likely)

While leptospirosis (Weil's disease) can present with fever, jaundice, renal failure, and thrombocytopenia 7, 8, it typically causes:

  • Direct (conjugated) hyperbilirubinemia with elevated transaminases
  • More prominent hepatocellular injury pattern
  • Exposure history (contaminated water, animal contact)

The indirect hyperbilirubinemia pattern and normal transaminases make leptospirosis unlikely here.

Gilbert syndrome 9, 10 causes isolated indirect hyperbilirubinemia but would not explain the thrombocytopenia, fever, or acute urinary retention.

Prognosis

With prompt plasma exchange and corticosteroid therapy, TTP has significantly improved outcomes. However, untreated TTP carries a mortality rate exceeding 90%, emphasizing the critical importance of immediate recognition and treatment 1. The organ damage in TTP is largely reversible with early appropriate treatment, and usual critical care outcome predictors do not apply 1.

References

Guideline

diagnosis of infection in sepsis.

Intensive Care Medicine, 2001

Research

Expert Consensus on the Diagnosis and Management of Inherited Hyperbilirubinemia (2025).

Journal of clinical and translational hepatology, 2026

Related Questions

In a patient with recent icterus, markedly elevated total bilirubin (predominantly conjugated), high alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, gamma‑glutamyl transferase, lactate dehydrogenase, and splenomegaly, do these liver test results indicate Gilbert syndrome?
How should I evaluate a transient rise in unconjugated bilirubin in a 58-year-old postmenopausal woman with mild isolated unconjugated hyperbilirubinemia, borderline anemia, normal liver enzymes and synthetic function, normal vitamin B12, low reticulocyte production index, and normal abdominal ultrasound?
What is the appropriate workup for hepatopathy in patients with indirect hyperbilirubinemia?
In an 18-year-old male with an isolated total bilirubin of 2.3 mg/dL and normal complete blood count (CBC) and comprehensive metabolic panel (CMP), what is the most likely cause?
What is the likely etiology of the mildly elevated total bilirubin and transaminases in a 53‑year‑old woman with borderline hemoglobin A1c and modest dyslipidemia, and how should these liver function abnormalities be evaluated and managed?
Is venlafaxine (Effexor) metabolized by the cytochrome P450 enzyme CYP2D6?
What serum and immunohistochemical markers are used to detect epithelial-derived cancers?
Should a post‑transfusion platelet count be obtained, and what is the optimal timing for drawing the sample after the infusion?
Is a free T4 level of 0.80 ng/dL normal, given a TSH of 2.78 mIU/L?
What is the appropriate workup and treatment for a patient who develops gross hematuria during urinary tract infections?
What is the appropriate venlafaxine dosing strategy for a patient who is a CYP2D6 intermediate metabolizer?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.